Sorensen; Brit Binow
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sorensen; Brit Binow.The latest application filed is for "antibodies against tissue factor pathway inhibitor".
- Sorensen; Brit Binow - Birkerod N/A DK
- Sorensen; Brit Binow - Birkeroed DK
| Patent | Date |
|---|---|
| Antibodies against tissue factor pathway inhibitor Grant 8,361,469 - Hilden , et al. January 29, 2 | 2013-01-29 |
| Antibodies Against Tissue Factor Pathway Inhibitor App 20110318356 - Hilden; Ida ; et al. | 2011-12-29 |
| SUBCUTANEOUS ADMINISTRATION OF COAGULATION FACTOR VIIa-RELATED POLYPEPTIDES App 20100143326 - Rischel; Christian ; et al. | 2010-06-10 |
| Human tissue factor antibodies App 20050169927 - Freskgaard, Per-Ola ; et al. | 2005-08-04 |
| Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis Grant 6,858,587 - Sorensen , et al. February 22, 2 | 2005-02-22 |
| Human tissue factor antibodies App 20040001830 - Freskgaard, Per-Ola ; et al. | 2004-01-01 |
| Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis App 20030125255 - Sorensen, Brit Binow ; et al. | 2003-07-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 